Danish drugmaker Novo Nordisk is aiming for a big slice of the multibillion-doll...
) is aiming for a big slice of the multibillion-dollar diabetes market with a new pill, approved by U.S. authorities on Friday, that caters for patients with an aversion to needles.
The company built its position as the world’s biggest insulin maker on the back of injectable drugs, but now aims to transform the market with a first-of-its-kind tablet version of its semaglutide drug. “We have only worked with around 25% of the patients so far and we see it as a breakthrough because we can now also address the tablet-based market,” chief scientific officer Mads Krogsgaard Thomsen told Reuters on Monday.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
New voting rights documentary targets #hashtag, Facebook audiences ahead of 2020 electionBrave New Films is looking to cyberspace to find audiences for its new documentary on voter suppression ahead of the 2020 presidential election.
Consulte Mais informação »
Fed's Williams: 'We were prepared' for the overnight funding jolt last weekNew York Fed President John Williams said Monday that the central bank acted quickly during last week's jolt to overnight lending markets and that the issue appears resolved for now.
Consulte Mais informação »
This Squash Casserole Is the Answer to Weeknight Vegetarian LasagnaThinly slice squash and layer it with ricotta cheese for a hearty casserole that is just as cozy and filling.
Consulte Mais informação »